How do film-coating weight gains affect tablet dissolution profiles?

Typical weight gains of 2–4% provide adequate moisture and taste protection without delaying dissolution beyond pharmacopeial limits. Exceeding 5% can slow disintegration unless super-disintegrants are incorporated into the core [12]. Read More

What capital investment is required to retrofit a batch coating line to continuous operation?

Retrofitting a single conventional pan line to continuous operation typically costs USD 1.5–3.0 million, including PAT instrumentation and control-system integration [3]. Read More

How are CDMOs differentiating their coating service offerings?

Leading CDMOs invest in multi-layer and modified-release validated platforms, offering regulatory filing support that smaller sponsors cannot maintain in-house [13]. Read More

What role does particle size distribution play in coating uniformity?

Narrow particle size distributions ensure even spray coverage and minimize inter-tablet coating weight variation. Bimodal distributions above 15% RSD often trigger re-granulation [12]. Read More

How do environmental regulations impact solvent-based coating adoption?

VOC emission limits in the EU and parts of Asia have largely eliminated organic solvent coatings from new installations, directing investment toward aqueous and dry-powder alternatives [4]. Read More

What quality tests are mandatory for coated tablet release?

Release specifications typically include coating weight gain, disintegration time, dissolution profile, and visual defect assessment per USP <1151> guidelines [1]. Read More

How does the Tablet Coating Market address cold-chain oral dosage challenges?

Moisture-barrier coatings using PVDC or PVA copolymers extend shelf life in tropical zones without cold-chain requirements, reducing distribution costs by up to 20% [18]. Read More

Tablet Coating Market (2026 - 2035)

Tablet Coating Market Research Report By Coating Type (Sugar Coating, Film Coating, Enteric Coating, Sustained-Release Coating), By Application (Pharmaceutical Tablets, Nutraceutical Tablets, Confectionery Tablets), By End-Use Industry (Pharmaceutical Industry, Nutraceutical Industry, Food and Beverage Industry), By Equipment Type (Pan Coaters, Fluid Bed Coaters, Carousel Coaters, Tablet Compression Coaters), By Formulation (Aqueous-Based Coatings, Solvent-Based Coatings, Powder-Based Coatings) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2026-2035

CAGR

5.48%

2025 Market Size

USD 1.06 Billion (2025)

2035 Market Size

USD 1.81 Billion (2035)

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/23063-HCR | Pages: 100 | Author: Satyendra Maurya, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Continuous Manufacturing Adoption | |
  2. 3.1.2 Generic Drug Volume Expansion | |
  3. 3.1.3 Regulatory Quality Tightening (cGMP) | |
  4. 3.1.4 TiO₂ Reformulation Mandates | |
  5. 3.1.5 CDMO Outsourcing Acceleration | |
  6. 3.1.6 Oral Biologics Delivery Programs | |
  7. 3.1.7 India PLI Scheme Incentives |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 Raw-Material Price Volatility | |
  2. 3.2.2 High Validation Costs for Coating Changes | |
  3. 3.2.3 Skilled Operator Shortages | |
  4. 3.2.4 Environmental Solvent Regulations | |
  5. 3.2.5 Patent Cliffs Reducing Branded R&D Spend |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Oral Biologics Delivery Platforms | |
  2. 3.3.2 Sustainable and Clean-Label Coating Systems | |
  3. 3.3.3 Emerging-Market Capacity Build-Out | |
  4. 3.3.4 Digital Twin and Real-Time Release Testing | |
  5. 3.3.5 CDMO Specialization in Complex Coatings |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Tablet Coating Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Coating Type | |
  1. 5.1.1 Film-Coated | |
  2. 5.1.2 Sugar-Coated | |
  3. 5.1.3 Enteric-Coated | |
  4. 5.1.4 Others |
2. 5.2 By Polymer | |
  1. 5.2.1 Cellulose Ethers | |
  2. 5.2.2 Acrylic Acid Polymers | |
  3. 5.2.3 Others |
3. 5.3 By Formulation Component | |
  1. 5.3.1 Plasticizers | |
  2. 5.3.2 Colorants | |
  3. 5.3.3 Others |
4. 5.4 By Process / Equipment | |
  1. 5.4.1 Conventional Pan Coating | |
  2. 5.4.2 Fluidized-Bed Coating | |
  3. 5.4.3 Continuous Coating Systems |
5. 5.5 By Application | |
  1. 5.5.1 Immediate-Release | |
  2. 5.5.2 Sustained-Release | |
  3. 5.5.3 Delayed-Release | |
  4. 5.5.4 Others |
6. 5.6 By End-User | |
  1. 5.6.1 Pharmaceutical Manufacturers | |
  2. 5.6.2 CDMOs / CMOs | |
  3. 5.6.3 Nutraceutical Companies
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Colorcon Inc. | |
  2. 7.3.2 BASF SE | |
  3. 7.3.3 Evonik Industries AG | |
  4. 7.3.4 Ashland Global Holdings | |
  5. 7.3.5 Kerry Group plc | |
  6. 7.3.6 Shin-Etsu Chemical Co. | |
  7. 7.3.7 Merck KGaA | |
  8. 7.3.8 Sensient Technologies | |
  9. 7.3.9 Gattefossé SAS | |
  10. 7.3.10 DuPont de Nemours
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Driven Process Optimization |
2. 8.2 Platform Economics and Modular Equipment |
3. 8.3 Sustainability and Solvent-Free Coating Systems |
4. 8.4 Convergence with Advanced Drug Delivery
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES
13 LIST OF FIGURES

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Coating Type	Film-Coated, Sugar-Coated, Enteric-Coated, Others	Film-Coated	Enteric-Coated
Polymer	Cellulose Ethers, Acrylic Acid Polymers, Others	Cellulose Ethers	Acrylic Acid Polymers
Formulation Component	Plasticizers, Colorants, Others	Plasticizers	Colorants
Process / Equipment	Conventional Pan Coating, Fluidized-Bed Coating, Continuous Coating Systems	Conventional Pan Coating	Continuous Coating Systems
Application	Immediate-Release, Sustained-Release, Delayed-Release, Others	Immediate-Release	Sustained-Release
End-User	Pharmaceutical Manufacturers, CDMOs / CMOs, Nutraceutical Companies	Pharmaceutical Manufacturers	CDMOs / CMOs

Market Segmentation Overview

By Coating Type

Sub-Segment	Key Trend
Film-Coated	Shift toward aqueous HPMC and PVA systems; TiO₂-free formulations gaining traction.
Sugar-Coated	Declining share as film coatings offer faster processing and lower weight gain.
Enteric-Coated	Fastest-growing segment driven by acid-labile API pipelines and targeted GI delivery
Others	Includes sub-coating, seal-coating, and specialty hybrid systems

Film coating remains the industry standard for oral solid dosage finishing, though the enteric-coated segment is attracting disproportionate R&D investment as pharmaceutical pipelines prioritize site-specific intestinal delivery.

By Polymer

Sub-Segment	Key Trend
Cellulose Ethers	HPMC and HPC remain the workhorse polymers with the deepest regulatory dossier history
Acrylic Acid Polymers	Eudragit platform enables precise pH-triggered release across coating configurations.
Others	PVA, shellac, pullulan, and emerging biopolymer alternatives

Cellulose ethers benefit from multi-decade pharmacopeial acceptance, while acrylic copolymers lead innovation in functional and enteric coating design.

By Formulation Component

Sub-Segment	Key Trend
Plasticizers	Triethyl citrate and PEG grades dominate; flexibility and adhesion optimization.
Colorants	Iron oxides and lake pigments replacing TiO₂ across European formulations
Others	Anti-tacking agents, opacifiers, and surfactants

Plasticizers anchor the largest component share as they are essential to every film and enteric coating formulation for achieving crack-free, uniform coverage.

By Process / Equipment

Sub-Segment	Key Trend
Conventional Pan Coating	Large installed base sustains share; incremental automation upgrades underway.
Fluidized-Bed Coating	Preferred for pellet and multiparticulate coating; Wurster process dominance.
Continuous Coating Systems	Fastest growing process segment; PAT integration and real-time release driving adoption

Conventional pans maintain the largest equipment base, but continuous systems are rapidly gaining ground as drug makers invest in next-generation manufacturing lines.

By Application

Sub-Segment	Key Trend
Immediate-Release	Largest application; standard protective and aesthetic coating for mass-market tablets
Sustained-Release	Fastest growing; chronic-disease adherence programs drive adoption
Delayed-Release	Enteric-targeted coatings for acid-sensitive APIs
Others	Pulsatile, chronotherapeutic, and combination-release platforms

Immediate-release coatings serve the broadest product base, while sustained-release applications are accelerating on the back of growing chronic-disease treatment demand.

By End-User

Sub-Segment	Key Trend
Pharmaceutical Manufacturers	In-house coating capabilities remain dominant; vertical integration preference.
CDMOs / CMOs	Fastest growing; complex coating outsourcing and regulatory filing support
Nutraceutical Companies	Growing demand for coating in dietary supplements and functional foods

Pharmaceutical manufacturers control the majority of coating demand, but the structural shift toward outsourcing complex multi-layer coating work is positioning CDMOs as the fastest-growing end-user category.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”